JPS61204189A - Production of novel compound having penam ring - Google Patents

Production of novel compound having penam ring

Info

Publication number
JPS61204189A
JPS61204189A JP60043375A JP4337585A JPS61204189A JP S61204189 A JPS61204189 A JP S61204189A JP 60043375 A JP60043375 A JP 60043375A JP 4337585 A JP4337585 A JP 4337585A JP S61204189 A JPS61204189 A JP S61204189A
Authority
JP
Japan
Prior art keywords
formula
acetate
mmol
ethyl
acetic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP60043375A
Other languages
Japanese (ja)
Inventor
Chikara Kaneko
金子 主税
Takao Chiba
千葉 卓男
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Priority to JP60043375A priority Critical patent/JPS61204189A/en
Publication of JPS61204189A publication Critical patent/JPS61204189A/en
Pending legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

PURPOSE:To obtain the titled compound useful as a synthetic intermediate for penicillin compounds, easily, by treating a specific thiazolidine-2-acetic acid derivative with triphenylphosphine and 2,2-dipyridyl-disulfide in acetonitrile. CONSTITUTION:The objective compound of formula II (e.g. 6-methyl-7-oxo-4- thia-1-azabicyclo[3.2.0]heptane) can be produced by treating the thiazolidine-2- acetic acid derivative of formula I [R1 and R2 are lower alkyl; A is CH2-CH2, C(CH3)2-CH(COOR), or CH2-CH(COOR) (R is H or protecting group)] with preferably equimolar amount of or slightly excess triphenylphosphine and 2,2-dipyridyl- sulfide in acetonitrile under ice-cooling-heat-refluxing.

Description

【発明の詳細な説明】 方法に関する。ペニシリン類に代表されるペナム環を有
する化合物は抗生物質として宵用である。
DETAILED DESCRIPTION OF THE INVENTION A method. Compounds having a penum ring, such as penicillins, are used as antibiotics.

ペニシリン類等のペナム環を有する化合物の合成法とし
ては数多くの方法が知られているが、合成工程数または
処理操作等の点で工業生産上満足すべきものは多くない
Although many methods are known for synthesizing penam ring-containing compounds such as penicillins, there are not many methods that are satisfactory for industrial production in terms of the number of synthesis steps or treatment operations.

本発明者等はペナム環を膏する化合物の工業生産上有用
な製造法につき鋭意研究した結果、容易に入手し得る原
料から得られる一般式(II)で示されるチアゾリジン
−2−酢酸誘導体をアセトニトリル中でトリフェニルホ
スフィンおよび2,2−ジビリジルジスルフイドで処理
することにより一般式(I)で示されるペナム環を有す
る化合物が容易に得られることを見出し更に検討を加え
て本発明を完成した。
As a result of intensive research into a manufacturing method useful for industrial production of penum ring-containing compounds, the present inventors have discovered that the thiazolidine-2-acetic acid derivative represented by the general formula (II) obtained from readily available raw materials can be prepared using acetonitrile. They discovered that a compound having a penam ring represented by the general formula (I) can be easily obtained by treating the compound with triphenylphosphine and 2,2-dipyridyl disulfide, and after further study, they completed the present invention. did.

(I)          (1? [式中RCH2は各々同−又は異なって水素原子又は低
級アルキル基を意味し、Aは−CH2−CH。
(I) (1? [In the formula, RCH2 is the same or different and each represents a hydrogen atom or a lower alkyl group, and A is -CH2-CH.

+、−c (CH,)、−CH(COOR)+、又は−
CH2−CH(COOR)−(但しRは水素原子又はカ
ルボキシル基の保護基を意味する)である] 本発明のアセトニトリル中、トリフェニルホスフィンお
よび2.2−ジピリジルジスルフィドで処理するという
方法は、Mukai5’ama−Ohno法[J 、 
Am、Ch em、S o c、+ 103+2406
 (1981)コとして知られている方法であるが、ペ
ナム環の合成に使用された例はない。
+, -c (CH,), -CH(COOR)+, or -
CH2-CH(COOR)- (wherein R means a hydrogen atom or a protecting group for a carboxyl group)] The method of treating with triphenylphosphine and 2,2-dipyridyl disulfide in acetonitrile of the present invention is described in Mukai5 'ama-Ohno method [J,
Am, Chem, Soc, +103+2406
(1981), but this method has never been used to synthesize a penum ring.

本発明は文献未記載の新規かつを用な方法である。The present invention is a novel method that has not been described in any literature.

本発明を実施するに当たって、反応はアセトニトリル中
で行われる。トリフェニルホスフィンおよび2.2−ジ
ピリジルジスルフィドの使用量は出発物質である化合物
(n)に対し等モル量又はやや過剰に用いると好ましい
結果が得られる。
In practicing the invention, reactions are conducted in acetonitrile. Preferable results can be obtained when triphenylphosphine and 2,2-dipyridyl disulfide are used in equimolar amounts or slightly in excess of the starting material, compound (n).

反応温度は反応規模および反応時間との関係で水側乃至
加熱還流の条件間で適宜選択される。反応混合物から目
的化合物(I)の単離は常法により、例えば反応混合物
から溶媒を留去した後、残渣をカラムクロマトグラフィ
ー等の手段に付すことにより行われる。
The reaction temperature is appropriately selected between the water side and heating reflux conditions depending on the reaction scale and reaction time. Isolation of the target compound (I) from the reaction mixture is carried out by a conventional method, for example, by distilling off the solvent from the reaction mixture and subjecting the residue to a means such as column chromatography.

本発明において出発物質として一般式(It)で示され
るチアゾリジン−2−酢酸類の酸塩、例えば塩酸塩を用
いる場合は反応の際に有機塩基、例えばトリエチルアミ
ンを加えることにより行われる。
In the present invention, when an acid salt of thiazolidine-2-acetic acid represented by general formula (It), such as hydrochloride, is used as a starting material, an organic base such as triethylamine is added during the reaction.

なお、本発明の一般式(n)で示されるチアゾリジン−
2−酢酸類は一部新規化合物を含むが、例えば以下式示
するA)およびB)の方法により容易に製造できる。
In addition, thiazolidine- represented by the general formula (n) of the present invention
Although 2-acetic acids include some new compounds, they can be easily produced, for example, by methods A) and B) shown below.

およびAは前記と同じものを意味する)この反応式にお
いて一般式(IV)で示される化合物の具体例を挙げれ
ば、システアミン又はシスティン、ペニシラミン若しく
はこれらのカルボキシル基が低級アルキル基等で保護さ
れた化合物である。
and A means the same as above) In this reaction formula, specific examples of compounds represented by the general formula (IV) include cysteamine, cysteine, penicillamine, or compounds whose carboxyl groups are protected with a lower alkyl group, etc. It is a compound.

本発明の方法によって得られる一般式(I)で示される
化合物はそれ自体安定である。またそのペナム環の6位
は種々の反応に対し活性であり、例えば一般式(I)の
化合物においてRi、R2のうち少なくともひとつが水
素原子である化合物はその6位に種々の置換基を導入す
ることが可能であり、他のペニシリン類の合成中間体と
しても用いることができる。
The compound of general formula (I) obtained by the method of the present invention is itself stable. In addition, the 6-position of the penum ring is active for various reactions; for example, in the compound of general formula (I), in which at least one of Ri and R2 is a hydrogen atom, various substituents can be introduced at the 6-position. It can also be used as a synthetic intermediate for other penicillins.

参考例1 a)エチル2−エトキシカルボニルプロピオンイミデー
ト塩酸塩(1000mg、  4.8  mmo l)
システアミン塩酸塩(542mg、  4.8  mm
 o l )およびトリエチルアミン(482mg、 
 4.8mmoりをエタノール(20ml)中、4時間
加熱還流する。溶媒を減圧下で留去した後、炭酸水素ナ
トリウム水溶液を加え、塩化メチレンで抽出する。塩化
メチレン層を水洗し、硫酸マグネシウムで乾燥後、溶媒
を減圧下で留去する。残渣をシリカゲルカラムクロマト
グラフィー(シリカゲル15g。
Reference Example 1 a) Ethyl 2-ethoxycarbonylpropionimidate hydrochloride (1000 mg, 4.8 mmol)
Cysteamine hydrochloride (542 mg, 4.8 mm
o l ) and triethylamine (482 mg,
4.8 mmol was heated under reflux in ethanol (20 ml) for 4 hours. After the solvent is distilled off under reduced pressure, an aqueous sodium hydrogen carbonate solution is added, and the mixture is extracted with methylene chloride. The methylene chloride layer is washed with water, dried over magnesium sulfate, and then the solvent is distilled off under reduced pressure. The residue was subjected to silica gel column chromatography (15 g of silica gel).

ヘキサン−酢酸エチル、4:1)で精製し、無色油状物
としてエチル α −メ チ ル −2−チ ア ゾ 
リ/−2−アセテートを得る。収量573mg (64
%)このものはIRおよびNMRスペクトルにおいてエ
チルgd−チアゾリジンー2−アセテートとの平衡混合
物として存在する。
Purified with hexane-ethyl acetate (4:1) as a colorless oil.
li/-2-acetate is obtained. Yield 573mg (64
%) which is present in the IR and NMR spectra as an equilibrium mixture with ethyl gd-thiazolidine-2-acetate.

エチル α−メ ルー −アゾlン一 −アセテートI
R(CHCI  )   :1730.1820cm’
Ethyl α-mer-azo-acetate I
R(CHCI): 1730.1820cm'
.

NMR(CDCI、’)δ: 1.25 (3H,t、
 J=7Hz)。
NMR (CDCI,')δ: 1.25 (3H,t,
J=7Hz).

1、43 (3H,d、 J=7Hz)、 2.97〜
4.43(7H,m)。
1, 43 (3H, d, J=7Hz), 2.97~
4.43 (7H, m).

エ ル  −チアゾ1ジン−−アセテ−IR(CHCI
3)   :3300,1640cm”’。
L-Thiazo1dine--acetate-IR (CHCI
3) :3300,1640cm"'.

NMR(CDCI3)δ: 1.25 (3H,t)、
  1.80 (3H。
NMR (CDCI3) δ: 1.25 (3H,t),
1.80 (3H.

s)、 2.97〜4.43 (8H,m)、 7.9
7〜8.43(IHL b r s)。
s), 2.97-4.43 (8H, m), 7.9
7-8.43 (IHL b r s).

b)前記a)で得たエチル α −メ チ ル −2−
チアゾリン−2−アセテート(100mg、  0.5
mmol)のメタノール(3,0m1)溶液に、20%
塩化水素−メタノール溶液(塩化水素ガス2.0g、 
 メタノール10m1)を用いて約pH4に調整した後
、N a B H3CN (32mg、O−5mmol
)を加えpH3〜4に保つように塩化水素−メタノール
溶液を適宜追加し、水冷下4時間撹拌する。反応後水を
加え、炭酸水素ナトリウム水溶液を加え、塩化メチレン
で抽出する。塩化メチレン層を硫酸マグネシウムで乾燥
した後、溶媒を減圧下で留去する。残渣をシリカゲルカ
ラムクロマトグラフィー(シリカゲル8g、ヘキサン−
酢酸エチル、4:1)で精製して無色油状物としてエチ
ルα−メチルチアゾリジン−2−アセテートを得る。こ
のものはジアステレオマーの混合物である。収量55m
g (54%)。
b) Ethyl α-methyl-2- obtained in a) above
Thiazoline-2-acetate (100mg, 0.5
mmol) in methanol (3.0ml) solution, 20%
Hydrogen chloride-methanol solution (hydrogen chloride gas 2.0g,
After adjusting the pH to about 4 using methanol (10 ml), Na B H3CN (32 mg, O-5 mmol
), add hydrogen chloride-methanol solution as appropriate to keep the pH at 3 to 4, and stir for 4 hours under water cooling. After the reaction, water is added, an aqueous sodium hydrogen carbonate solution is added, and the mixture is extracted with methylene chloride. After drying the methylene chloride layer with magnesium sulfate, the solvent is distilled off under reduced pressure. The residue was purified by silica gel column chromatography (8 g of silica gel, hexane-
Purification with ethyl acetate (4:1) gives ethyl α-methylthiazolidine-2-acetate as a colorless oil. This is a mixture of diastereomers. Yield 55m
g (54%).

IR(CHCI3)   :3300.1720cm’
IR (CHCI3): 3300.1720cm'
.

NMR(CDCI 3)δ: 1.30 (3H,t、
 J=7Hz)。
NMR (CDCI 3) δ: 1.30 (3H,t,
J=7Hz).

1、31.1.34 (3H,d、 J=7Hz)、 
2.13(IH,brs)、 2. ’40〜3.80
 (5H,m)。
1, 31.1.34 (3H, d, J=7Hz),
2.13 (IH, brs), 2. '40~3.80
(5H, m).

4、17 (2H,Q、 J=7Hz)、 4.62.
4.85(IH,d、 J==7Hz) C)前記b)で得たエチルα−メチルチアゾリジン−2
−アセート(800mg、  3.2  mmo f)
を濃塩酸(7,0m1)中水治下で2時間攪拌する。水
(2,0m1)を加え、室温でさらに13時間撹拌する
。溶媒を減圧下で留去し、得られるアメ状の残渣にエー
テル−アセトン混合溶媒を加え結晶化させた後、ろ取し
てα−メチルチアンリジン−2−酢酸塩酸塩を得る。収
量281mg(45%)。
4, 17 (2H, Q, J=7Hz), 4.62.
4.85 (IH, d, J==7Hz) C) Ethyl α-methylthiazolidine-2 obtained in b) above
-acetate (800 mg, 3.2 mmof)
The mixture was stirred in concentrated hydrochloric acid (7.0 ml) under water for 2 hours. Add water (2.0 ml) and stir for a further 13 hours at room temperature. The solvent is distilled off under reduced pressure, and the resulting candy-like residue is crystallized by adding an ether-acetone mixed solvent, and then filtered to obtain α-methylthianlysine-2-acetic acid hydrochloride. Yield 281 mg (45%).

IR(Nujol)     :3800〜2200.
1710cm−1゜NMR(DMSO−d l )δ:
 1.25 (3/2. H,d。
IR (Nujol): 3800-2200.
1710 cm-1° NMR (DMSO-d l ) δ:
1.25 (3/2. H, d.

J=8Hz)、 1.35 (3/2H,d、 J=8
Hz)。
J=8Hz), 1.35 (3/2H, d, J=8
Hz).

2、90〜3.83 (5H,m) 、 4.68 (
1/2H,d。
2, 90-3.83 (5H, m), 4.68 (
1/2H, d.

J=9Hz)、 4.90 (1/2H,d、 J=8
Hz)。
J=9Hz), 4.90 (1/2H, d, J=8
Hz).

8、70〜11.70 (2H,br)。8, 70-11.70 (2H, br).

参考例2 a)エチル2−エトキシカルボニル−2−メチルプロピ
オンイミデート塩酸塩(1,73g、 7.7mmol
)、  ンステアミン塩酸塩(0,88g。
Reference Example 2 a) Ethyl 2-ethoxycarbonyl-2-methylpropionimidate hydrochloride (1.73 g, 7.7 mmol
), Nsteamine hydrochloride (0,88 g.

7.7mmol)およびトリエチルアミン(0、78g
、 7.7 mmo l)をエタノール(30ml)中
7時間加熱還流する。以下参考例1a)に記載の方法と
同様に処理し無色油状物としてエチルα、α−ジメチル
ー2−チアゾリン−2−アセテートを得る。収量0.9
2g(68%)。
7.7 mmol) and triethylamine (0.78 g
, 7.7 mmol) in ethanol (30 ml) for 7 hours under reflux. The following treatment is carried out in the same manner as described in Reference Example 1a) to obtain ethyl α,α-dimethyl-2-thiazoline-2-acetate as a colorless oil. Yield 0.9
2g (68%).

IR(CHCI  )   :1725cm−’。IR (CHCI): 1725cm-'.

NMR(CDCI、)δ: 1.27 (3H,t、J
=7Hz)。
NMR (CDCI,) δ: 1.27 (3H,t,J
=7Hz).

1、50 (6H,s)、 3.28 (2H,t、 
J=8Hz)。
1,50 (6H,s), 3.28 (2H,t,
J=8Hz).

4、20 (2H,q、 J=7Hz)、 4.25 
(2H,t。
4, 20 (2H, q, J=7Hz), 4.25
(2H, t.

J=8Hz)。J=8Hz).

b)前記a)で得たエチルα、α−ジメチルー2−チア
ゾリン−2−アセテ−) (looomg。
b) Ethyl α,α-dimethyl-2-thiazoline-2-acetate obtained in a) above (loooomg.

5mmol)のメタノール(30ml)溶液に、塩化水
素−メタノール溶液を加え約pH4に調整した後、N 
a B H3CN (313mg、 5mmo l)を
加え、pH3〜4に保つように塩化水素−メタメール溶
液を適宜追加し、水冷下 1.5 時間撹拌する。以下
参考例1b)に記載の方法と同様に処理し、エチルα、
α−ジメチルチアゾリジン−2−アセテートを無色油状
物として得る。
5 mmol) in methanol (30 ml), a hydrogen chloride-methanol solution was added to adjust the pH to approximately 4, and then N
aB H3CN (313 mg, 5 mmol) is added, hydrogen chloride-metamer solution is added appropriately to keep the pH at 3 to 4, and the mixture is stirred for 1.5 hours under water cooling. The following treatment was carried out in the same manner as described in Reference Example 1b), and ethyl α,
α-Dimethylthiazolidine-2-acetate is obtained as a colorless oil.

収1t468mg(46%)。Yield: 1 ton 468 mg (46%).

IR(CHCIJ)   :3300,1715cm 
IR (CHCIJ): 3300, 1715cm
.

NMR(CDCI3)δ: 1.27 (3H,t、 
J=7Hz)。
NMR (CDCI3) δ: 1.27 (3H,t,
J=7Hz).

1、28 (3H,s)、 1.33 (3H,、s)
、 2.43(LH,brs)、 2.53〜3.12
 (3H,m)s 3.32〜3.70 (IH,m)
、 4.15 (2H,q、 J=7Hz)。
1,28 (3H,s), 1.33 (3H,,s)
, 2.43 (LH, brs), 2.53-3.12
(3H, m)s 3.32~3.70 (IH, m)
, 4.15 (2H,q, J=7Hz).

4.60 (IH,s)。4.60 (IH, s).

C)前記b)で得たエチル α 、  α −ジ メ 
チ ル チアゾリジン−2−アセテート(200mg、
  0.99mmol)を濃塩酸(3,5m1)中、7
0℃で5時間加熱する。以下参考例1.0)に記載の方
法と同様に処理しα、α−ジメチルチアゾリジンー2−
酢酸塩酸塩を得る。収量198mg (95%)。
C) Ethyl α, α-dimethyl obtained in b) above
Thiazolidine-2-acetate (200mg,
0.99 mmol) in concentrated hydrochloric acid (3.5 ml)
Heat at 0°C for 5 hours. Hereinafter, α,α-dimethylthiazolidine-2-
Acetic acid hydrochloride is obtained. Yield 198 mg (95%).

1’R(Nujol)   :3800−2000.1
705cm−’。
1'R (Nujol): 3800-2000.1
705cm-'.

NMR(CD300)δ: 1.35 (3H,s)、
 1.40(3H,s)、 3.05〜3.92 (4
H,m)、 4.97(IH,s)。
NMR (CD300) δ: 1.35 (3H, s),
1.40 (3H, s), 3.05~3.92 (4
H, m), 4.97 (IH, s).

参考例3 a)エチルエトキシエトキシ力ルポニルアセトイミデー
ト塩酸塩(3,91g、  0.02 mol)システ
アミン塩酸塩(2,27g、  0.02  mo 1
)およびトリエチルアミン(2,02g、 0.02m
ol)をエタノ−71/ 40 m I中、so’cで
2時間加熱する。溶媒を減圧下で留去した後、炭酸水素
ナトリウム水溶液を加え、塩化メチレンで抽出する。塩
化メチレン層を水洗し、硫酸ナトリウムで乾燥後、塩化
メチレンを1減圧下で留去する。残渣をヘキサンより再
結晶し無色プリズム晶としてエチル2−チアゾリン−2
−アセテートを得る。
Reference Example 3 a) Ethyl ethoxyethoxyluponylacetimidate hydrochloride (3,91 g, 0.02 mol) Cysteamine hydrochloride (2,27 g, 0.02 mo 1
) and triethylamine (2.02g, 0.02m
ol) in ethanol-71/40 mI for 2 hours in so'c. After the solvent is distilled off under reduced pressure, an aqueous sodium hydrogen carbonate solution is added, and the mixture is extracted with methylene chloride. The methylene chloride layer is washed with water, dried over sodium sulfate, and then methylene chloride is distilled off under reduced pressure. The residue was recrystallized from hexane to give ethyl 2-thiazoline-2 as colorless prism crystals.
- Obtain acetate.

収量 2.25g(85%)融点57〜59℃。Yield 2.25g (85%) Melting point 57-59°C.

b)前記a)で得たエチル2−チアゾリン−2−アセテ
ート(173mg、1mmo I)のメタノール3ml
の溶液に、20%塩化水素−メタノール溶液(塩化水素
ガス2.0g、  メタノール10m1)を加え約pH
4に調整する。水冷下撹拌しなからNa BH3CN(
63mg、1mmol)を加え、pH3〜4に保つよう
に塩化水素−メタノール溶液を適宜追加しく約0.3m
1)、30分間水冷下撹拌する。以下参考例1.b)に
記載の方法と同様に処理し、エチルチアゾリジン−2−
アセテートを無色油状物として得る。
b) 3 ml of methanol of ethyl 2-thiazoline-2-acetate (173 mg, 1 mmol I) obtained in a) above
Add a 20% hydrogen chloride-methanol solution (2.0 g of hydrogen chloride gas, 10 ml of methanol) to the solution and adjust the pH to approximately
Adjust to 4. While stirring under water cooling, Na BH3CN (
63 mg, 1 mmol), and add hydrogen chloride-methanol solution as appropriate to keep the pH at 3 to 4 for about 0.3 m
1) Stir for 30 minutes under water cooling. Reference example 1 below. Treated in the same manner as described in b), ethylthiazolidine-2-
Acetate is obtained as a colorless oil.

収量114mg (85%)。Yield: 114 mg (85%).

IR(CHCI  ):3300.1720cm’。IR (CHCI): 3300.1720cm'.

NMR(CDCI、)δ: 1.27 (3H,t、 
J=7Hz)。
NMR (CDCI,) δ: 1.27 (3H,t,
J=7Hz).

2、15 (IH,brs)、 2.80 (2H,d
、 J=8Hz)。
2, 15 (IH, brs), 2.80 (2H, d
, J=8Hz).

2、88〜3.82 (4H,m)、 4.17 (2
H,q。
2,88~3.82 (4H,m), 4.17 (2
H,q.

J=7Hz)、 4.83 (IH,tt J=6Hz
)。
J=7Hz), 4.83 (IH,tt J=6Hz
).

C)エチルプロピオレート、システアミン塩酸塩および
トリエチルアミンを各々等モル量用い、エタノール中室
温で10時間反応させる。以下この反応混合物を参考例
1.a)に記載の方法と同様の処理を行い精製しエチル
チアゾリジン−2−アセテートを得る。収率65%。こ
のものの物性値は前記b)で得られたものと一致した。
C) Using equimolar amounts of ethyl propiolate, cysteamine hydrochloride and triethylamine, each is reacted in ethanol at room temperature for 10 hours. This reaction mixture will be described as Reference Example 1 below. Purification is carried out in the same manner as described in a) to obtain ethylthiazolidine-2-acetate. Yield 65%. The physical properties of this product were consistent with those obtained in b) above.

d)前記b)またはC)で得られたエチルチア/リジン
−2−アセテートを濃塩酸中、水冷下で1時間撹拌する
。次いで反応液の半量の水を加えさらに一昼夜撹拌する
。溶媒を減圧下に留去する。
d) Ethylthia/lysine-2-acetate obtained in b) or C) above is stirred in concentrated hydrochloric acid for 1 hour under water cooling. Next, half the amount of water to the reaction solution was added, and the mixture was further stirred overnight. The solvent is removed under reduced pressure.

以下参考例1.0)に記載の方法と同様に処理しチアゾ
リジン−2−酢酸塩酸塩を得る。融点103〜105℃
Thiazolidine-2-acetic acid hydrochloride is obtained by treating in the same manner as described in Reference Example 1.0). Melting point 103-105℃
.

IR(KBr)      :2770〜2260.1
715cm’NMR(DMSO−d、)δ: 2.95
〜3.78 (6H,m) 。
IR (KBr): 2770-2260.1
715cm'NMR (DMSO-d,) δ: 2.95
~3.78 (6H, m).

4、93 (IH,dd、  J=6.0および8.0
Hz)、9.0〜11.0 (2H,b r)。
4,93 (IH, dd, J=6.0 and 8.0
Hz), 9.0-11.0 (2H, b r).

実施例1 参考例1.0)で得たα−メチルチアゾリジン−2−酢
酸塩酸塩(150mg、  o、78  mmo l)
、トリフェニルホスフィ7 (240mg、  0.9
2m m o l )および2,2−ジピリジルジスル
フィド(202mg、  0.92  mmol)のア
セトニトリル(75ml)溶液に、水側下撹拌しながら
トリエチルアミ7 (77mgw  0.76mmol
)を加え、さらに4時間水冷下撹拌する。溶媒を室温減
圧下で留去した後、シリカゲルカラムクロマトグラフィ
ー(シリカゲル18g、ヘキサン−酢酸エチル、5:1
)に付し無色油状物として6−メチル−7−オキソ−4
−チア−1−アザビシクロ[3,2,Oコヘブタンを得
る。収量76 m g(70%)、MSm/z : 1
43 (M )t 11588、87.56゜ IR(CHCI  ):1760cm−’。
Example 1 α-Methylthiazolidine-2-acetic acid hydrochloride (150 mg, o, 78 mmol) obtained in Reference Example 1.0)
, triphenylphosphine 7 (240mg, 0.9
2 mmol) and 2,2-dipyridyl disulfide (202 mg, 0.92 mmol) in acetonitrile (75 ml) was added triethylamide 7 (77 mg w 0.76 mmol) with stirring under the water side.
) and stirred for an additional 4 hours under water cooling. After distilling off the solvent at room temperature under reduced pressure, silica gel column chromatography (18 g of silica gel, hexane-ethyl acetate, 5:1
) to give 6-methyl-7-oxo-4 as a colorless oil.
-Thia-1-azabicyclo[3,2,O-cohebutane is obtained. Yield 76 mg (70%), MSm/z: 1
43 (M)t 11588, 87.56°IR (CHCI): 1760 cm-'.

NMR(CDC13)δ: 1.42 (3H,d、J
=7.5Hz)。
NMR (CDC13) δ: 1.42 (3H, d, J
=7.5Hz).

2、65〜3.30 (4H,m)、 4.15 (I
H,ddd。
2, 65-3.30 (4H, m), 4.15 (I
H,ddd.

J=10.5.5.5および3.5Hz)、4.62 
(IH。
J = 10.5, 5.5 and 3.5Hz), 4.62
(IH.

J=1.4Hz)。J=1.4Hz).

実施例2 参考例2.0)で得たα、α−ジメチルチアゾリンジン
ー2−酢酸塩酸塩(100mg、  0.47mmol
)、トリフェニルホスフィ o、511Jmmo 1)、2.2−ジピジルジスフィ
ド (130mg、  0.59  mmo l)およ
びトリエチルアミ7 (48mg、  0.47 mm
ol)をアセトニトリル(50ml)を用い、以下実施
例1と同様に処理し6,6−シメチルー7−オキソー4
−チア−1−アザビシクロ[3,2,0コヘブタンを無
色結晶として得る。
Example 2 α,α-dimethylthiazolindine-2-acetic acid hydrochloride (100 mg, 0.47 mmol) obtained in Reference Example 2.0)
), triphenylphosphine o, 511Jmmo 1), 2,2-dipidyldisphide (130mg, 0.59 mmol) and triethylamide 7 (48mg, 0.47 mm
ol) was treated with acetonitrile (50 ml) in the same manner as in Example 1 to obtain 6,6-dimethyl-7-oxo 4
-thia-1-azabicyclo[3,2,0 cohebutane is obtained as colorless crystals.

収量52mg(71%)。融点34℃。Yield 52 mg (71%). Melting point: 34°C.

MSm/z : 157 (M”)、 129.88.
87.70゜IR(CHCl3):1755cm’。
MSm/z: 157 (M”), 129.88.
87.70°IR (CHCl3): 1755 cm'.

NMR(CC1,)δ: 1.15 (3H,s)、 
1.45 (3H。
NMR (CC1,) δ: 1.15 (3H, s),
1.45 (3H.

s)、 2.45〜3.15 (3H,m)、 3.9
0〜4.30(IH,m)、 4.70 (IH,s)
s), 2.45-3.15 (3H, m), 3.9
0 to 4.30 (IH, m), 4.70 (IH, s)
.

実施例3 参考例3.d)で得たチアゾリジン−2−酢酸塩酸塩(
0,OIM、アセトニトリル溶液)、トリフェニルホス
フィン(1,2mo 1等ff1) 、 2゜2−ジピ
リジルジスルフィド(1,2mo1等量)、およびトリ
エチルアミン(1,1mo1等量)を水冷下3時間攪拌
する。以下実施例1と同様に処理し7−オキソ−4−チ
ア−1−アザビシクロ[3,2,Oコヘブタンを無色油
状物として得る。
Example 3 Reference example 3. d) Thiazolidine-2-acetic acid hydrochloride (
0, OIM, acetonitrile solution), triphenylphosphine (1,2 mo 1 etc. ff1), 2゜2-dipyridyl disulfide (1,2 mo 1 equiv.), and triethylamine (1,1 mo 1 equiv.) were stirred for 3 hours under water cooling. . Thereafter, the same procedure as in Example 1 was carried out to obtain 7-oxo-4-thia-1-azabicyclo[3,2,O-cohebutane as a colorless oil.

IR(CHCl、):1775cm−’。IR (CHCl, ): 1775 cm-'.

High  resolution  MSm/z計算
値(C,H7NO8として):129.0248 (M
  )、実測値:129.0272(M )。
High resolution MSm/z calculation value (as C, H7NO8): 129.0248 (M
), actual value: 129.0272 (M ).

Claims (1)

【特許請求の範囲】 一般式▲数式、化学式、表等があります▼ [式中R_1およびR_2は各々同一又は異なって水素
原子又は低級アルキル基を意味し、Aは−CH_2−C
H_2−、−C(CH_3)_2−CH(COOR)−
又は−CH_2−CH(COOR)−(但しRは水素原
子又はカルボキシル基の保護基を意味する)である]で
示される化合物をアセトニトリル中、トリフェニルホス
フィンおよび2,2−ジピリジルジスルフィドで処理す
ることを特徴とする一般式▲数式、化学式、表等があり
ます▼ (式中R_1、R_2およびAは前記と同じものを意味
する)で示される化合物の製法。
[Claims] General formula ▲ Numerical formula, chemical formula, table, etc. ▼ [In the formula, R_1 and R_2 are the same or different and each represents a hydrogen atom or a lower alkyl group, and A is
H_2-, -C(CH_3)_2-CH(COOR)-
or -CH_2-CH(COOR)- (where R means a hydrogen atom or a protecting group for a carboxyl group)] with triphenylphosphine and 2,2-dipyridyl disulfide in acetonitrile. A method for producing a compound represented by the general formula ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (in the formula, R_1, R_2 and A mean the same as above).
JP60043375A 1985-03-05 1985-03-05 Production of novel compound having penam ring Pending JPS61204189A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60043375A JPS61204189A (en) 1985-03-05 1985-03-05 Production of novel compound having penam ring

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60043375A JPS61204189A (en) 1985-03-05 1985-03-05 Production of novel compound having penam ring

Publications (1)

Publication Number Publication Date
JPS61204189A true JPS61204189A (en) 1986-09-10

Family

ID=12662084

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60043375A Pending JPS61204189A (en) 1985-03-05 1985-03-05 Production of novel compound having penam ring

Country Status (1)

Country Link
JP (1) JPS61204189A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4805695A (en) * 1986-04-25 1989-02-21 Sumitomo Heavy Industries, Ltd. Counterflow heat exchanger with floating plate

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4805695A (en) * 1986-04-25 1989-02-21 Sumitomo Heavy Industries, Ltd. Counterflow heat exchanger with floating plate

Similar Documents

Publication Publication Date Title
JP6832946B2 (en) How to prepare kinase inhibitors and their intermediates
JPS61155358A (en) Diallylbutyric acid derivative and production thereof
JPH01211567A (en) Novel sulfonamide compound
JPS63165387A (en) Production of (+)-biotin
JPS63310882A (en) Polyoxygenated labdane derivative and manufacture
SU649313A3 (en) Method of obtaining indole derivatives or salts thereof
GB2101986A (en) Thiazolinoazetidinone derivatives
JPS61204189A (en) Production of novel compound having penam ring
JP2001521498A (en) Method for producing O- (3-amino-2-hydroxy-propyl) -hydroxymic acid halide
JP3536480B2 (en) 4,5-Dihalogeno-6-dihalogenomethylpyrimidine and process for producing the same
US4098791A (en) Process for preparing 3-(cyanimino)-3-amino-propionitriles
JPS61200977A (en) Novel thiazolidine derivative
SU471711A3 (en) Method for producing α-aminoacrylic acid derivatives
JPS5944312B2 (en) Production method of indazole derivatives
JP2641879B2 (en) Preparation of optically active hydantoin derivatives
JPH069642A (en) 4-desoxy-4-epipodophyllotoxin derivative and its salt
KR800001133B1 (en) Process for preparing 5-sulfamoyl benzoic acid substituted by heterocyclic compound
JPS58192874A (en) Novel spiroisoxazoline derivative
JPH02304090A (en) Preparation of polycyclic compound
JPH0558977A (en) Novel intermediate compound for producing indolealkaloid derivative
JPH0827148A (en) Production of dithiazolium salt
JPS59216882A (en) Production of 2,4-oxazolidinedione derivative
JPS61277673A (en) Novel thiazolidine derivative
JPH0753704B2 (en) Process for producing phenylmalonic acid monoanilide derivative and 3-phenyl-2-quinolone derivative
JPH04178366A (en) Production of 3-amino-4-methylene pyrrolidine derivative